Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Aug 15, 2024; 16(8): 3635-3650
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3635
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3635
Figure 10 The mRNA expression levels of estrogen receptor 1, epidermal growth factor receptor, cytochrome P450 family 3 subfamily A member 4, mitogen-activated protein kinase 14, cytochrome P450 family 1 subfamily A member 2, and cytochrome p450 family 2 subfamily B member 6.
aP < 0.05 vs 0 μmol/L; bP < 0.01 vs 0 μmol/L; cP < 0.001 vs 0 μmol/L. ESR1: Estrogen receptor 1; EGFR: Epidermal growth factor receptor; CYP3A4: Cytochrome P450 family 3 subfamily A member 4; MAPK14: Mitogen-activated protein kinase 14; CYP1A2: Cytochrome P450 family 1 subfamily A member 2; CYP2B6: Cytochrome P450 family 2 subfamily B member 6.
- Citation: Yang PH, Wei YN, Xiao BJ, Li SY, Li XL, Yang LJ, Pan HF, Chen GX. Curcumin for gastric cancer: Mechanism prediction via network pharmacology, docking, and in vitro experiments. World J Gastrointest Oncol 2024; 16(8): 3635-3650
- URL: https://www.wjgnet.com/1948-5204/full/v16/i8/3635.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i8.3635